% | $
Quotes you view appear here for quick access.

Nymox Pharmaceutical Corporation Message Board

  • mox_police mox_police Apr 19, 2000 4:12 PM Flag

    Insider buying?


    how many shares of nymx are
    owned by members of the Board of Directors (aside from
    Dr A)?

    The person with the right answer wins
    free ad7c test - spinal tap version.


    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Novartis AG Gets FDA OK To Market Exelon
      Jones Newswires
      EAST HANOVER, N.J. -- Novartis AG's
      (Z.NOV) Novartis Pharmaceuticals Corp. received Food and
      Drug Administration approval to market Exelon, a
      cholinesterase inhibitor for the treatment of patients with mild
      to moderate Alzheimer's disease.

      In a press
      release Friday, the company said Exelon is now cleared
      for marketing in nearly 70 countries.

      Platt; Dow Jones Newswires; 201-938-5400

      • 1 Reply to tansexygrl
      • The market potential for Alzheimer's diagnostics
        (screening and monitoring therapy) is estimated to be
        $6-800M in the US alone. Quite frankly, I didn't acquire
        this stock with the drug therapy in mind...rather to
        play the diagnostic products. Unless NYMX gets a BIG
        Pharma partner to develop any compound, they should
        stick to the diagnostic side. The Serex thing gives
        them a number of new and exciting options there. Hey,
        just one investors opinion...p.s. love your screen

4.02+0.05(+1.26%)Jul 25 4:00 PMEDT